Nov 08, 2023 / 08:00PM GMT
Trung Chuong Huynh - UBS Investment Bank, Research Division - Analyst
Okay. We're at the hour now. My name is Trung Huynh. I'm the U.S. pharma analyst here at UBS. Thank you, everyone, for joining in the room and also online. It's my pleasure today to host Eli Lilly, and we've got Patrik Jonsson, the President of Lilly Immunology. But upon Mike Mason's retirement, he's going to be -- his new title will be President of Lilly Diabetes and Obesity as well as the President of Lilly USA. So welcome, Patrik.
Patrik Jonsson - Eli Lilly and Company - EVP, Chief Customer Officer, President of Lilly Diabetes & Obesity and President Lilly USA
Thank you so much, Trung.
Questions and Answers:
Trung Chuong Huynh - UBS Investment Bank, Research Division - AnalystWe've got Lilly on a momentous day today with the approval of Zepbound. So I appreciate there's going to be a lot of interest in diabetes and the obesity space, but I will be touching later on in immunology, which is Patrik's current day job at the moment.
Trustpilot
